Intellia Therapeutics, Inc.;Regeneron Pharmaceuticals, Inc.
发明人:
John Finn,Hon-Ren Huang
申请号：
US16657939
公开号：
US20200268906A1
申请日:
2019.10.18
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Nucleic acid constructs that allow insertion and/or expression of a sequence of interest, such as a transgene, are provided. Compositions and methods of using such constructs for expression of a polypeptide or therapeutic agent, for example, are also provided.
